They produce CCL4, which consequently in turn acts on microglia, prompting them to release CCL5, which is crucial for the stem cells of low-grade glioma to survive and grow.97 This study suggests that CD8+ T cells are not always beneficial in killing tumor cells. This evidence concerns the gene CCL5 and central nervous system cancer.